Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion type Assertion NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_head.
- NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion wasGeneratedBy ECO_0000203 NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_provenance.
- NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion wasDerivedFrom gad-20150221 NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_provenance.
- NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion SIO_000772 12397416 NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_provenance.
- NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion evidence source_evidence_literature NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_provenance.
- NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_assertion description "[Genotyping assays based on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were used to determine the frequency of polymorphisms in CYP1A1 (3'-flanking region), CYP2E1 (5'-flanking region and intron 6), EPHX1 (exon 3 and exon 4), NQO1 (exon 6), GSTM1 (deletion), GSTP1 (exon 5), and GSTT1 (deletion) in a case-control study composed of 219 patients with morbus Hodgkin (MH) and non-Hodgkin's lymphomas (NHL) and 455 age- and gender-matched healthy individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55487.RAPlbR4Et9QV2DCwa2vbRGa-lHvOgJsIpWr3yevDkP8Eo130_provenance.